[
  {
    "ts": null,
    "headline": "TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts",
    "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.2% year on year to $316.2 million. Its non-GAAP profit of $0.56 per share was 10.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=1abe06ce7bb1df51d0c0ab886521e702573242b501e8f8d1b02737934531656d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749575714,
      "headline": "TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts",
      "id": 135171388,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.2% year on year to $316.2 million. Its non-GAAP profit of $0.56 per share was 10.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=1abe06ce7bb1df51d0c0ab886521e702573242b501e8f8d1b02737934531656d"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Bio-Techne Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10",
    "summary": "Presenter SpeechMatthew Sykes Good morning, everyone. My name is Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs. And today, I have the pleasure of welcoming Jim Hippel,...",
    "url": "https://finnhub.io/api/news?id=5a81ac2fbcc35100cc0aff709812ed1d43a60683b7ab20d2df48853c540cb820",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749557123,
      "headline": "Transcript : Bio-Techne Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10",
      "id": 135157861,
      "image": "",
      "related": "TECH",
      "source": "Finnhub",
      "summary": "Presenter SpeechMatthew Sykes Good morning, everyone. My name is Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs. And today, I have the pleasure of welcoming Jim Hippel,...",
      "url": "https://finnhub.io/api/news?id=5a81ac2fbcc35100cc0aff709812ed1d43a60683b7ab20d2df48853c540cb820"
    }
  },
  {
    "ts": null,
    "headline": "ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics",
    "summary": "ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing in India.",
    "url": "https://finnhub.io/api/news?id=548aa98e378c03dbdbea0a59139d471967f4df8eb289a238b6b528f5d5033da0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749553200,
      "headline": "ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics",
      "id": 135149498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing in India.",
      "url": "https://finnhub.io/api/news?id=548aa98e378c03dbdbea0a59139d471967f4df8eb289a238b6b528f5d5033da0"
    }
  }
]